Worthy journals

Ivermectin worthy of further investigation.

Page 1 of 3 Letter Ivermectin worthy of further investigation by Andrew C Steer, Therese Kearns, Ross M Andrews, James S McCarthy, Jonathan R Carapetis & Bart J Currie a Centre for International Child Health, University of Melbourne, Melbourne, Australia. b Menzies School of Health Research, Charles Darwin University, Darwin, Australia. c Queensland Institute of Medical Research, University of ...

Is Bleomycin a worthy alternative?

Bleomycin is an antibiotic discovered in 1966 and used as anti-cancer drug. It has also been used as sclerosant for lymphatic malformation with good results and minimum side effect. Like any sclerosant agent, bleomycin is popular for the treatment of lymphatic malformation with publication as recent as in January 2011.[1] Unlike surgery, sclerotherapy is better specially for avoiding injury to ...

Bleomycin: A worthy alternative

CONTEXT Lymphangiomas are developmental anomalies presenting mainly in the first two years of life. Surgical excision has been the mainstay of treatment; however a potentially disfiguring surgery along with presence of important structures in the vicinity and infiltration into surrounding structures makes the dissection difficult. AIMS To study the safety and efficacy of Bleomycin as a sclero...

Healthier environments as a worthy program goal.

Osteoporosis Prevention—A Worthy and Achievable Strategy

This special issue of Nutrients records seven of the presentations made to the very successful meeting titled " Osteoporosis Prevention: A Workshop on Calcium, Vitamin D and other Nutritional Aspects " held in Adelaide, Australia on 5 and 6 March 2010 [1-7]. Seventy six delegates attended from across Australia and New Zealand to review the current evidence that dietary calcium intake, vitamin D...